Skip to main content

Food Insecurity

0
Pipeline Programs
5
Companies
5
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Human BioSciences
Human BioSciencesWV - Martinsburg
2 programs
In-hospital food support interventionN/A1 trial
Shamba MaishaN/A1 trial
Active Trials
NCT06946355Recruiting9,119Est. Dec 2029
NCT07043647Recruiting410Est. Feb 2029
Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
1 program
High-Stress InterventionN/A1 trial
Active Trials
NCT05191030Completed453Est. Sep 2025
Purdue Pharma
Purdue PharmaCT - Stamford
1 program
Indiana SNAP-EdN/A1 trial
Active Trials
NCT03436589Completed575Est. Mar 2015
Alliance Pharmaceuticals
1 program
Unconditional Cash TransferN/A1 trial
Active Trials
NCT05176743Completed44Est. Jun 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
Human BioSciencesShamba Maisha
Human BioSciencesIn-hospital food support intervention
Angeles TherapeuticsHigh-Stress Intervention
Alliance PharmaceuticalsUnconditional Cash Transfer
Purdue PharmaIndiana SNAP-Ed

Clinical Trials (5)

Total enrollment: 10,601 patients across 5 trials

An Agricultural Livelihood Intervention for Pregnant Women

Start: Sep 2025Est. completion: Feb 2029410 patients
N/ARecruiting
NCT06946355Human BioSciencesIn-hospital food support intervention

Food-based Support for Hospitalized Children and Their Families

Start: May 2025Est. completion: Dec 20299,119 patients
N/ARecruiting
NCT05191030Angeles TherapeuticsHigh-Stress Intervention

Cortisol and Food Insecurity

Start: Mar 2022Est. completion: Sep 2025453 patients
N/ACompleted
NCT05176743Alliance PharmaceuticalsUnconditional Cash Transfer

Food Insecurity in Oncology

Start: Aug 2021Est. completion: Jun 202244 patients
N/ACompleted

The Indiana SNAP-Ed Long-term Study

Start: Sep 2013Est. completion: Mar 2015575 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 actively recruiting trials targeting 10,601 patients
5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.